AR037327A1 - Compuestos policiclicos, composiciones farmaceuticas que los comprenden, uso de tales compuestos para la preparacion de medicamentos y procedimiento para producir dichos compuestos - Google Patents
Compuestos policiclicos, composiciones farmaceuticas que los comprenden, uso de tales compuestos para la preparacion de medicamentos y procedimiento para producir dichos compuestosInfo
- Publication number
- AR037327A1 AR037327A1 ARP020103723A ARP020103723A AR037327A1 AR 037327 A1 AR037327 A1 AR 037327A1 AR P020103723 A ARP020103723 A AR P020103723A AR P020103723 A ARP020103723 A AR P020103723A AR 037327 A1 AR037327 A1 AR 037327A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- compounds
- aliphatic ring
- forms
- cycloalkyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 7
- 239000003814 drug Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 12
- 125000001931 aliphatic group Chemical group 0.000 abstract 12
- 125000000217 alkyl group Chemical group 0.000 abstract 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 10
- 229910052757 nitrogen Inorganic materials 0.000 abstract 10
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 8
- 125000003545 alkoxy group Chemical group 0.000 abstract 7
- 229910052739 hydrogen Inorganic materials 0.000 abstract 7
- 239000001257 hydrogen Substances 0.000 abstract 7
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 6
- 125000003118 aryl group Chemical group 0.000 abstract 5
- 229910052760 oxygen Inorganic materials 0.000 abstract 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 4
- 229910052717 sulfur Inorganic materials 0.000 abstract 4
- 125000003342 alkenyl group Chemical group 0.000 abstract 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 2
- 125000004644 alkyl sulfinyl group Chemical group 0.000 abstract 2
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 2
- 125000004414 alkyl thio group Chemical group 0.000 abstract 2
- 125000002947 alkylene group Chemical group 0.000 abstract 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 2
- 125000000000 cycloalkoxy group Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 125000005842 heteroatom Chemical group 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- -1 hydroxy, mercapto Chemical class 0.000 abstract 2
- 239000001301 oxygen Substances 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 239000011593 sulfur Substances 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 125000003302 alkenyloxy group Chemical group 0.000 abstract 1
- 125000005530 alkylenedioxy group Chemical group 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 abstract 1
- 125000004438 haloalkoxy group Chemical group 0.000 abstract 1
- 125000001188 haloalkyl group Chemical group 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 125000003367 polycyclic group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01123908 | 2001-10-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR037327A1 true AR037327A1 (es) | 2004-11-03 |
Family
ID=8178868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP020103723A AR037327A1 (es) | 2001-10-05 | 2002-10-02 | Compuestos policiclicos, composiciones farmaceuticas que los comprenden, uso de tales compuestos para la preparacion de medicamentos y procedimiento para producir dichos compuestos |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6680326B2 (https=) |
| EP (1) | EP1436293B1 (https=) |
| JP (1) | JP4369229B2 (https=) |
| KR (1) | KR100676114B1 (https=) |
| CN (1) | CN1284781C (https=) |
| AR (1) | AR037327A1 (https=) |
| AT (1) | ATE316971T1 (https=) |
| AU (1) | AU2002342752B2 (https=) |
| BR (1) | BR0213122A (https=) |
| CA (1) | CA2461572C (https=) |
| DE (1) | DE60209029T2 (https=) |
| ES (1) | ES2256552T3 (https=) |
| MX (1) | MXPA04003173A (https=) |
| PL (1) | PL370530A1 (https=) |
| RU (1) | RU2315050C2 (https=) |
| WO (1) | WO2003031444A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6946472B2 (en) * | 2002-04-30 | 2005-09-20 | Hoffman-La Roche Inc. | Polycyclic compounds exhibiting anti-tumor activities |
| US20060189893A1 (en) * | 2005-01-06 | 2006-08-24 | Diamics, Inc. | Systems and methods for detecting abnormal cells |
| US20060161076A1 (en) * | 2005-01-06 | 2006-07-20 | Diamics, Inc. | Systems and methods for collection of cell clusters |
| CN103204781B (zh) * | 2013-03-14 | 2015-04-01 | 武汉大学 | 2,7–二取代芴酮衍生物及其制备方法与应用 |
| CN110448555B (zh) * | 2019-09-10 | 2020-10-23 | 河南省人民医院 | 多环化合物在制备抗肿瘤药物中的应用及抗肿瘤药物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW440562B (en) * | 1994-05-20 | 2001-06-16 | Taiho Pharmaceutical Co Ltd | Condensed-indan derivative and pharmaceutically acceptable salts thereof |
| WO1998045272A1 (en) * | 1997-04-07 | 1998-10-15 | Latrobe University | Topoisomerase inhibitors |
| FR2801309B1 (fr) | 1999-11-18 | 2002-01-04 | Adir | Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2002
- 2002-09-25 RU RU2004114245/04A patent/RU2315050C2/ru not_active IP Right Cessation
- 2002-09-25 US US10/254,951 patent/US6680326B2/en not_active Expired - Fee Related
- 2002-09-25 PL PL02370530A patent/PL370530A1/xx not_active Application Discontinuation
- 2002-09-25 KR KR1020047004899A patent/KR100676114B1/ko not_active Expired - Fee Related
- 2002-09-25 MX MXPA04003173A patent/MXPA04003173A/es active IP Right Grant
- 2002-09-25 EP EP02779413A patent/EP1436293B1/en not_active Expired - Lifetime
- 2002-09-25 AT AT02779413T patent/ATE316971T1/de active
- 2002-09-25 BR BR0213122-6A patent/BR0213122A/pt not_active IP Right Cessation
- 2002-09-25 CA CA2461572A patent/CA2461572C/en not_active Expired - Fee Related
- 2002-09-25 WO PCT/EP2002/010722 patent/WO2003031444A1/en not_active Ceased
- 2002-09-25 DE DE60209029T patent/DE60209029T2/de not_active Expired - Lifetime
- 2002-09-25 ES ES02779413T patent/ES2256552T3/es not_active Expired - Lifetime
- 2002-09-25 AU AU2002342752A patent/AU2002342752B2/en not_active Ceased
- 2002-09-25 CN CNB028197712A patent/CN1284781C/zh not_active Expired - Fee Related
- 2002-09-25 JP JP2003534427A patent/JP4369229B2/ja not_active Expired - Fee Related
- 2002-10-02 AR ARP020103723A patent/AR037327A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2256552T3 (es) | 2006-07-16 |
| US6680326B2 (en) | 2004-01-20 |
| CA2461572A1 (en) | 2003-04-17 |
| WO2003031444A1 (en) | 2003-04-17 |
| JP4369229B2 (ja) | 2009-11-18 |
| US20030073691A1 (en) | 2003-04-17 |
| CN1610681A (zh) | 2005-04-27 |
| CN1284781C (zh) | 2006-11-15 |
| PL370530A1 (en) | 2005-05-30 |
| RU2004114245A (ru) | 2005-06-27 |
| MXPA04003173A (es) | 2004-07-27 |
| CA2461572C (en) | 2011-02-15 |
| KR100676114B1 (ko) | 2007-02-02 |
| BR0213122A (pt) | 2004-09-21 |
| RU2315050C2 (ru) | 2008-01-20 |
| EP1436293A1 (en) | 2004-07-14 |
| JP2005504846A (ja) | 2005-02-17 |
| AU2002342752B2 (en) | 2007-11-15 |
| EP1436293B1 (en) | 2006-02-01 |
| DE60209029D1 (de) | 2006-04-13 |
| ATE316971T1 (de) | 2006-02-15 |
| KR20040048926A (ko) | 2004-06-10 |
| DE60209029T2 (de) | 2006-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP066383A (es) | Derivados de 5-fenil-4-metil-tiazol-2-il-amina como inhibidores de enzimas de cinasa fosfatidilinositol 3 (pi3) para el tratamiento de enfermedades inflamatorias de las vías respiratorias | |
| AR034390A1 (es) | Derivados de 1-sulfonil-tetrahidro quinolinas sustituidas, composiciones farmaceuticas y el uso de las mismas para la elaboracion de medicamentos como inhibidores de la gama secretasa | |
| CO6160288A2 (es) | Composiciones farmaceuticas que comprenden nilotinib o su sal | |
| BG104960A (en) | Bicyclic pirimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation | |
| AR037243A1 (es) | Antagonistas del receptor de adenosina a2a,a5-amino-imidazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]pirimidina, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento | |
| AR038000A1 (es) | Compuesto derivado de tien[2,3-d]pirimidin-2,4(1h,3h)-diona, composicion farmaceutica, proceso para su preparacion y su uso en la fabricacion de un medicamento | |
| ECSP056127A (es) | Inhibidores de 3-quinasa de fosfatidil-inositol | |
| AR024060A1 (es) | Nuevos compuestos farmaceuticamente activos | |
| AR058287A1 (es) | Derivados de isoquinolina y composicion farmaceutica | |
| AR046600A1 (es) | Diazaespiroalcanos y su uso como tratamiento para enfermedades mediadas por ccr8 | |
| PE20090042A1 (es) | Analogos de ciclopamina | |
| AR032467A1 (es) | Derivados de piridina, procedimiento para prepararlos, el uso de dichos derivados para la preparacion de medicamentos y los medicamentos que contienen dichos derivados | |
| ECSP034744A (es) | Antagonistas de nmda/nr2b no arilo-heterociclico n-sustituidos | |
| AR012593A1 (es) | Pirrolopiridinas sustituidas, composicion farmaceutica que las contiene, procedimiento para su preparacion y el uso de las mismas en la manufacturade un medicamento | |
| CR7698A (es) | Nuevos derivados de benzoimidazol utiles como agentes antiproliferativos | |
| AR049956A1 (es) | DERIVADOS DE 1,3 - OXAZOLIDIN - 2 - ONA COMO INHIBIDORES DE CETP Y ELEVADORES DEL NIVEL DE LAD-C; COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN Y SU USO EN LA FABRICACIoN DE UN MEDICAMENTO PARA EL TRATAMIENTO DE LA ATEROSCLEROSIS. | |
| PA8536001A1 (es) | Derivados de quinazolona como antagonistas de receptores adrenérgicos alfa-1a/b | |
| PE20211703A1 (es) | Compuesto derivado heterotriciclico novedoso y uso del mismo | |
| AR015312A1 (es) | Compuestos inhibidores no peptidilicos de la union a las celulas dependientes de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunesy respiratorias, composicion farmaceutica y uso de los compuestos en la preparacion de medicamentos | |
| ECSP045367A (es) | "derivados de bencimidazol utiles como antagonistas de histamina h3" | |
| AR043658A1 (es) | Derivados 8-substituidos-6,7,8,9-tetrahidropirimido[1,2-a]pirimidin-4-ona | |
| NO20070837L (no) | Pyrido-pyrido pyrimidinderivater, fremstilling derav samt terapeutisk anvendelse for behandling av cancer. | |
| AR037681A1 (es) | Antagonistas receptores de adenosina a2a de 5-amino-[1,2,4]-triazol biciclico, composiciones farmaceuticas que los comprenden, el uso de las mismas, solo o en combinacion de los compuestos y otros agentes para la preparacion de medicamentos utiles en el tratamiento de la enfermedad de parkinson y un | |
| AR058587A1 (es) | Compuestos de pirrolo-1,5-naftiridinona,su uso como agentes antibacterianos, composiciones farmaceuticas que los contienen y compuestos intermediarios para preparar dichos compuestos | |
| MXPA05006887A (es) | Derivados de 1-piperidin-4-il-4-pirrolidin-3-il-piperazina sustituidos y su uso como antagonistas de neurocininas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |